URINARY SOLUBLE VCAM-1 IS A USEFUL BIOMARKER OF DISEASE ACTIVITY AND TREATMENT RESPONSE IN LUPUS NEPHRITIS

被引：0
|
作者：
Gasparin, A. A. [1 ]
Pamplona Bueno de Andrade, N. [1 ]
Hax, V. [1 ]
Palominos, P. [1 ]
Siebert, M. [2 ]
Marx, R. [1 ]
Shaefer, P. [3 ]
Verissimo Veronese, F. [4 ]
Monticielo, O. [1 ]
机构：
[1] Univ Fed Rio Grande do Sul, Div Rheumatol, Dept Internal Med, Porto Alegre, RS, Brazil
[2] Hosp Clin Porto Alegre, Ctr Biotechnol, Porto Alegre, RS, Brazil
[3] Hosp Clin Porto Alegre, Dept Pathol, Porto Alegre, RS, Brazil
[4] Univ Fed Rio Grande do Sul, Div Nephrol, Dept Internal Med, Porto Alegre, RS, Brazil
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.199
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0412
引用
收藏
页码：1502 / 1503
页数：2
相关论文
共 50 条
  • [1] Urinary soluble VCAM-1 is a useful biomarker of disease activity and treatment response in lupus nephritis
    Gasparin, Andrese Aline
    Bueno de Andrade, Nicole Pamplona
    Hax, Vanessa
    Palominos, Penelope Esther
    Siebert, Marina
    Marx, Romulo
    Schaefer, Pedro Guilherme
    Veronese, Francisco Verissimo
    Monticielo, Odirlei Andre
    BMC RHEUMATOLOGY, 2020, 4 (01)
  • [2] Urinary soluble VCAM-1 is a useful biomarker of disease activity and treatment response in lupus nephritis
    Andrese Aline Gasparin
    Nicole Pamplona Bueno de Andrade
    Vanessa Hax
    Penélope Esther Palominos
    Marina Siebert
    Romulo Marx
    Pedro Guilherme Schaefer
    Francisco Veríssimo Veronese
    Odirlei André Monticielo
    BMC Rheumatology, 4
  • [3] Urinary VCAM-1 as a biomarker of lupus nephritis disease activity
    Eve Smith
    Rachel Corkhill
    Angela Midgley
    Louise Watson
    Caroline Jones
    Stephen Marks
    Kjell Tullus
    Clarissa Pilkington
    Michael W Beresford
    Pediatric Rheumatology, 12 (Suppl 1)
  • [4] Relationship between lupus nephritis activity and the serum level of soluble VCAM-1
    Ikeda, Y
    Fujimoto, T
    Ameno, M
    Shiiki, H
    Dohi, K
    LUPUS, 1998, 7 (05) : 347 - 354
  • [5] Plasma levels of soluble VCAM-1 are correlated to nephritis activity in proliferative lupus nephritis.
    Heimburger, M
    Jacobson, SH
    Sundelin, B
    Gunnarsson, I
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S200 - S200
  • [6] URINARY LEVELS OF VCAM-1 AND TWEAK AS BIOMARKERS OF LUPUS NEPHRITIS
    Urrego, T.
    Ortiz-Reyes, B.
    Aroca, G.
    Vanegas-Garcia, A. L.
    Cadena Bonfanti, A. A.
    Almendrales, L.
    Munoz, C. H.
    Gonzalez, L. A.
    Iglesias, A.
    Vasquez, G.
    Gomez-Puerta, J. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1239 - 1239
  • [7] Soluble TNF RII in Lupus Nephritis as a Biomarker of Disease Activity and Treatment Response
    Gupta, Ranjan
    Rajput, Sonam
    Kumar, Jayanth
    Mitra, Dipendra K.
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1313 - 1315
  • [8] Urinary soluble VCAM-1 in systemic lupus erythematosus: A clinical marker for monitoring disease activity and damage
    Molad, Y
    Miroshnik, E
    Sulkes, J
    Pitlik, S
    Weinberger, A
    Monselise, Y
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2002, 20 (03) : 403 - 406
  • [9] VCAM-1 EXPRESSION IN LUPUS NEPHRITIS AND CRESCENTIC NEPHRITIS
    MA, LJ
    WANG, HY
    KIDNEY INTERNATIONAL, 1995, 48 (02) : 597 - 597
  • [10] Urinary Angiostatin, CXCL4 and VCAM-1 As Biomarkers for Lupus Nephritis
    Mok, Chi Chiu
    Soliman, Samar
    Ho, Ling Yin
    Mohan, Chandra
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345